Hims & Hers Stock Plummets. The Wegovy Shortage Is Over.
The telehealth company has been selling a copycat version of a popular obesity drug during the recent shortage.
MarketWatch18m
FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
Hims & Hers shares HIMS were down 22.2% on Friday. However, the stock has surged more than 440% over the past 12 months. Back ...
Novo Nordisk Shares Rise After FDA Clears Shortage of Anti-Obesity Drugs
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...
Edina CPA, wanting ‘greater riches than she already had,’ gets prison for bilking $340K from clients
An Edina certified public accountant has received a prison term of more than two years for tapping into her clients’ bank ...